Chinese investor makes multi-million dollar bid for French pharma company

Chinese investors specializing in healthcare are increasingly expanding into the European market with a series of high-profile, strategic investments. This is part of a trend of heightened healthcare deal activity from Chinese investors. Last year, companies based in China announced acquisitions in the medical industry worth 30.4 billion USD – representing twice the investment level…

Middle Eastern healthcare investors turn to the US for stable returns

Investors based in the Middle East and regional healthcare companies having been actively seeking acquisitions and investment opportunities in the US. Overseas investments provide Middle Eastern individuals and institutions with a way to diversify their portfolios, rather than overexposing their operations to a single market, as noted recently in Forbes. According to Dhiraj Joshi, a…

Chinese VC firm invests 1 million USD in joint global healthcare venture

I-Bridge Capital, a health-care focused venture capital firm and incubator based in Shanghai, has announced the establishment of a joint venture with BioLineRx Ltd., a drug company based in Israel. The venture will incubate healthcare startups, in order to develop innovative clinical and pre-clinical therapeutic projects. Though these projects will originate primarily in Israel, they…